Showing results (431-440 of 844) with videos related to

Sort By:
Pageof 85
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1990
CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer--a phase I studyK R Beretta, K Hoeffken, S Kvinnsland, et al.
British Journal of Haematology|August 25, 1999
Angiogenic growth factors and endostatin in non-Hodgkin's lymphomaF Bertolini, M Paolucci, F Peccatori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99)D Hess, B Thürlimann, O Pagani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2013
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013A Goldhirsch, E P Winer, A S Coates, et al.
Journal of Neuroscience Research|May 21, 1999
Discoordinate regulation of different K channels in cultured rat skeletal muscle by nerve growth factorS Vigdor-Alboim, C Rothman, L Braiman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammationIdan Cohen, Peleg Rider, Yaron Carmi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2013
Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responsesMichael Brusilovsky, Moti Cordoba, Benyamin Rosental, et al.
Pageof 85